Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Transvenous Phrenic Nerve Stimulation for Diaphragm Protection in Acute Respiratory Failure: the STIMULUS I Clinical Trial

NCT05465083 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT05465083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05465083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Transvenous Phrenic Nerve Stimulation for Diaphragm Protection in Acute Respiratory Failure: the STIMULUS I Clinical Trial
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
February 4, 2023
Completion date
November 10, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute hypoxemic respiratory failure, diaphragm injury, lung injury